25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Epigenomics AG
Buy, Hold or Sell?

Let's analyze Epigenomics AG together

I guess you are interested in Epigenomics AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Epigenomics AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Epigenomics AG

I send you an email if I find something interesting about Epigenomics AG.

1. Quick Overview

1.1. Quick analysis of Epigenomics AG (30 sec.)










1.2. What can you expect buying and holding a share of Epigenomics AG? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€12.43
Expected worth in 1 year
€-51.74
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
€-64.17
Return On Investment
-4,861.3%

For what price can you sell your share?

Current Price per Share
€1.32
Expected price per share
€0.99 - €1.81
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Epigenomics AG (5 min.)




Live pricePrice per Share (EOD)
€1.32
Intrinsic Value Per Share
€272.07 - €337.17
Total Value Per Share
€284.49 - €349.60

2.2. Growth of Epigenomics AG (5 min.)




Is Epigenomics AG growing?

Current yearPrevious yearGrowGrow %
How rich?$10.7m$23.3m-$12.6m-117.5%

How much money is Epigenomics AG making?

Current yearPrevious yearGrowGrow %
Making money-$12.7m-$2.5m-$10.1m-79.8%
Net Profit Margin-2,479.2%-39.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Epigenomics AG (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Epigenomics AG?

Welcome investor! Epigenomics AG's management wants to use your money to grow the business. In return you get a share of Epigenomics AG.

First you should know what it really means to hold a share of Epigenomics AG. And how you can make/lose money.

Speculation

The Price per Share of Epigenomics AG is €1.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Epigenomics AG.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Epigenomics AG, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €12.43. Based on the TTM, the Book Value Change Per Share is €-16.04 per quarter. Based on the YOY, the Book Value Change Per Share is €15.60 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Epigenomics AG.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-15.53-1,176.4%-15.53-1,176.4%-3.30-250.3%-27.24-2,063.6%-27.24-2,063.6%
Usd Book Value Change Per Share-16.96-1,284.7%-16.96-1,284.7%16.501,249.6%2.63199.0%2.63199.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-16.96-1,284.7%-16.96-1,284.7%16.501,249.6%2.63199.0%2.63199.0%
Usd Price Per Share1.75-1.75-0.68-1.75-1.75-
Price to Earnings Ratio-0.11--0.11--0.21--0.11--0.11-
Price-to-Total Gains Ratio-0.10--0.10-0.04--0.01--0.01-
Price to Book Ratio0.13-0.13-0.02-0.11-0.11-
Price-to-Total Gains Ratio-0.10--0.10-0.04--0.01--0.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.395372
Number of shares716
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-16.962.63
Usd Total Gains Per Share-16.962.63
Gains per Quarter (716 shares)-12,142.161,881.11
Gains per Year (716 shares)-48,568.657,524.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-48569-48579075247514
20-97137-9714801504915038
30-145706-14571702257322562
40-194275-19428603009830086
50-242843-24285503762237610
60-291412-29142404514745134
70-339981-33999305267152658
80-388549-38856206019560182
90-437118-43713106772067706
100-485686-48570007524475230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Epigenomics AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---16.042-16.0420%15.604-203%2.485-745%2.485-745%
Book Value Per Share--12.42712.4270%28.469-56%20.851-40%20.851-40%
Current Ratio--2.1312.1310%11.065-81%4.912-57%4.912-57%
Debt To Asset Ratio--0.3580.3580%0.103+248%0.270+33%0.270+33%
Debt To Equity Ratio--0.5580.5580%0.115+386%0.412+36%0.412+36%
Dividend Per Share----0%-0%-0%-0%
Eps---14.689-14.6890%-3.125-79%-25.768+75%-25.768+75%
Free Cash Flow Per Share---16.357-16.3570%-5.389-67%-22.335+37%-22.335+37%
Free Cash Flow To Equity Per Share---16.357-16.3570%-5.389-67%-22.335+37%-22.335+37%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--337.171--------
Intrinsic Value_10Y_min--272.067--------
Intrinsic Value_1Y_max---6.767--------
Intrinsic Value_1Y_min---6.575--------
Intrinsic Value_3Y_max--10.575--------
Intrinsic Value_3Y_min--9.435--------
Intrinsic Value_5Y_max--65.178--------
Intrinsic Value_5Y_min--57.315--------
Market Cap--1358976.6321358976.6320%498048.026+173%1016331.417+34%1016331.417+34%
Net Profit Margin---24.792-24.7920%-0.391-98%-12.494-50%-12.494-50%
Operating Margin----0%-0%-0%-0%
Operating Ratio--27.76127.7610%1.693+1540%13.449+106%13.449+106%
Pb Ratio0.106-26%0.1340.1340%0.023+493%0.107+25%0.107+25%
Pe Ratio-0.090+20%-0.113-0.1130%-0.205+81%-0.114+1%-0.114+1%
Price Per Share1.320-26%1.6601.6600%0.641+159%1.654+0%1.654+0%
Price To Free Cash Flow Ratio-0.081+20%-0.101-0.1010%-0.119+17%-0.106+4%-0.106+4%
Price To Total Gains Ratio-0.082+20%-0.103-0.1030%0.041-352%-0.005-95%-0.005-95%
Quick Ratio--0.0080.0080%0.016-48%0.203-96%0.203-96%
Return On Assets---0.759-0.7590%-0.098-87%-0.875+15%-0.875+15%
Return On Equity---1.182-1.1820%-0.110-91%-1.353+14%-1.353+14%
Total Gains Per Share---16.042-16.0420%15.604-203%2.485-745%2.485-745%
Usd Book Value--10752821.20010752821.2000%23383052.000-54%13615025.160-21%13615025.160-21%
Usd Book Value Change Per Share---16.958-16.9580%16.495-203%2.627-745%2.627-745%
Usd Book Value Per Share--13.13613.1360%30.095-56%22.042-40%22.042-40%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---15.528-15.5280%-3.303-79%-27.239+75%-27.239+75%
Usd Free Cash Flow---14153511.900-14153511.9000%-4426077.700-69%-10835909.260-23%-10835909.260-23%
Usd Free Cash Flow Per Share---17.291-17.2910%-5.696-67%-23.611+37%-23.611+37%
Usd Free Cash Flow To Equity Per Share---17.291-17.2910%-5.696-67%-23.611+37%-23.611+37%
Usd Market Cap--1436574.1981436574.1980%526486.568+173%1074363.941+34%1074363.941+34%
Usd Price Per Share1.395-26%1.7551.7550%0.678+159%1.749+0%1.749+0%
Usd Profit---12710570.400-12710570.4000%-2566638.800-80%-11807807.000-7%-11807807.000-7%
Usd Revenue--512693.500512693.5000%6557191.300-92%2153946.960-76%2153946.960-76%
Usd Total Gains Per Share---16.958-16.9580%16.495-203%2.627-745%2.627-745%
 EOD+3 -3MRQTTM+0 -0YOY+3 -295Y+11 -2110Y+11 -21

3.3 Fundamental Score

Let's check the fundamental score of Epigenomics AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.090
Price to Book Ratio (EOD)Between0-10.106
Net Profit Margin (MRQ)Greater than0-24.792
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.008
Current Ratio (MRQ)Greater than12.131
Debt to Asset Ratio (MRQ)Less than10.358
Debt to Equity Ratio (MRQ)Less than10.558
Return on Equity (MRQ)Greater than0.15-1.182
Return on Assets (MRQ)Greater than0.05-0.759
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Epigenomics AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.320
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Epigenomics AG

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Epigenomics AG earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Epigenomics AG to the  industry mean.
  • A Net Profit Margin of -2,479.2% means that €-24.79 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Epigenomics AG:

  • The MRQ is -2,479.2%. The company is making a huge loss. -2
  • The TTM is -2,479.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,479.2%TTM-2,479.2%0.0%
TTM-2,479.2%YOY-39.1%-2,440.0%
TTM-2,479.2%5Y-1,249.4%-1,229.8%
5Y-1,249.4%10Y-1,249.4%0.0%
4.3.1.2. Return on Assets

Shows how efficient Epigenomics AG is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Epigenomics AG to the  industry mean.
  • -75.9% Return on Assets means that Epigenomics AG generated €-0.76 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Epigenomics AG:

  • The MRQ is -75.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -75.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-75.9%TTM-75.9%0.0%
TTM-75.9%YOY-9.8%-66.0%
TTM-75.9%5Y-87.5%+11.6%
5Y-87.5%10Y-87.5%0.0%
4.3.1.3. Return on Equity

Shows how efficient Epigenomics AG is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Epigenomics AG to the  industry mean.
  • -118.2% Return on Equity means Epigenomics AG generated €-1.18 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Epigenomics AG:

  • The MRQ is -118.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -118.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-118.2%TTM-118.2%0.0%
TTM-118.2%YOY-11.0%-107.2%
TTM-118.2%5Y-135.3%+17.1%
5Y-135.3%10Y-135.3%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Epigenomics AG.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Epigenomics AG is operating .

  • Measures how much profit Epigenomics AG makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Epigenomics AG to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Epigenomics AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Epigenomics AG is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 27.76 means that the operating costs are €27.76 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Epigenomics AG:

  • The MRQ is 27.761. The company is inefficient in keeping operating costs low. -1
  • The TTM is 27.761. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ27.761TTM27.7610.000
TTM27.761YOY1.693+26.068
TTM27.7615Y13.449+14.312
5Y13.44910Y13.4490.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Epigenomics AG.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Epigenomics AG is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 2.13 means the company has €2.13 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Epigenomics AG:

  • The MRQ is 2.131. The company is able to pay all its short-term debts. +1
  • The TTM is 2.131. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.131TTM2.1310.000
TTM2.131YOY11.065-8.933
TTM2.1315Y4.912-2.781
5Y4.91210Y4.9120.000
4.4.3.2. Quick Ratio

Measures if Epigenomics AG is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Epigenomics AG to the  industry mean.
  • A Quick Ratio of 0.01 means the company can pay off €0.01 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Epigenomics AG:

  • The MRQ is 0.008. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.008. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.008TTM0.0080.000
TTM0.008YOY0.016-0.008
TTM0.0085Y0.203-0.195
5Y0.20310Y0.2030.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Epigenomics AG.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Epigenomics AG assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Epigenomics AG to industry mean.
  • A Debt to Asset Ratio of 0.36 means that Epigenomics AG assets are financed with 35.8% credit (debt) and the remaining percentage (100% - 35.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Epigenomics AG:

  • The MRQ is 0.358. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.358. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.3580.000
TTM0.358YOY0.103+0.255
TTM0.3585Y0.270+0.088
5Y0.27010Y0.2700.000
4.5.4.2. Debt to Equity Ratio

Measures if Epigenomics AG is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Epigenomics AG to the  industry mean.
  • A Debt to Equity ratio of 55.8% means that company has €0.56 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Epigenomics AG:

  • The MRQ is 0.558. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.558. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.558TTM0.5580.000
TTM0.558YOY0.115+0.443
TTM0.5585Y0.412+0.147
5Y0.41210Y0.4120.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Epigenomics AG generates.

  • Above 15 is considered overpriced but always compare Epigenomics AG to the  industry mean.
  • A PE ratio of -0.11 means the investor is paying €-0.11 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Epigenomics AG:

  • The EOD is -0.090. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.113. Based on the earnings, the company is expensive. -2
  • The TTM is -0.113. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.090MRQ-0.113+0.023
MRQ-0.113TTM-0.1130.000
TTM-0.113YOY-0.205+0.092
TTM-0.1135Y-0.114+0.001
5Y-0.11410Y-0.1140.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Epigenomics AG:

  • The EOD is -0.081. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.101. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.101. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.081MRQ-0.101+0.021
MRQ-0.101TTM-0.1010.000
TTM-0.101YOY-0.119+0.017
TTM-0.1015Y-0.106+0.004
5Y-0.10610Y-0.1060.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Epigenomics AG is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.13 means the investor is paying €0.13 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Epigenomics AG:

  • The EOD is 0.106. Based on the equity, the company is cheap. +2
  • The MRQ is 0.134. Based on the equity, the company is cheap. +2
  • The TTM is 0.134. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.106MRQ0.134-0.027
MRQ0.134TTM0.1340.000
TTM0.134YOY0.023+0.111
TTM0.1345Y0.107+0.027
5Y0.10710Y0.1070.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets15,852
Total Liabilities5,680
Total Stockholder Equity10,172
 As reported
Total Liabilities 5,680
Total Stockholder Equity+ 10,172
Total Assets = 15,852

Assets

Total Assets15,852
Total Current Assets10,815
Long-term Assets5,037
Total Current Assets
Cash And Cash Equivalents 10,036
Net Receivables 42
Inventory 61
Other Current Assets 40
Total Current Assets  (as reported)10,815
Total Current Assets  (calculated)10,179
+/- 636
Long-term Assets
Property Plant Equipment 2,057
Intangible Assets 2,980
Long-term Assets  (as reported)5,037
Long-term Assets  (calculated)5,037
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,074
Long-term Liabilities606
Total Stockholder Equity10,172
Total Current Liabilities
Accounts payable 3,540
Other Current Liabilities 65
Total Current Liabilities  (as reported)5,074
Total Current Liabilities  (calculated)3,605
+/- 1,469
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt841
Long-term Liabilities  (as reported)606
Long-term Liabilities  (calculated)841
+/- 235
Total Stockholder Equity
Total Stockholder Equity (as reported)10,172
Total Stockholder Equity (calculated)0
+/- 10,172
Other
Capital Stock4,093
Common Stock Shares Outstanding 819
Net Invested Capital 10,172
Net Working Capital 5,741
Property Plant and Equipment Gross 4,522



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
21,827
13,989
6,797
24,663
15,852
15,85224,6636,79713,98921,827
   > Total Current Assets 
18,274
12,123
5,469
23,712
10,815
10,81523,7125,46912,12318,274
       Cash And Cash Equivalents 
16,463
10,155
3,566
23,049
10,036
10,03623,0493,56610,15516,463
       Short-term Investments 
653
880
961
0
0
00961880653
       Net Receivables 
164
40
205
34
42
423420540164
       Inventory 
364
313
122
176
61
61176122313364
       Other Current Assets 
62
90
40
414
40
40414409062
   > Long-term Assets 
3,553
1,866
1,328
951
5,037
5,0379511,3281,8663,553
       Property Plant Equipment 
0
1,533
1,184
892
2,057
2,0578921,1841,5330
       Intangible Assets 
474
333
145
60
2,980
2,98060145333474
> Total Liabilities 
3,214
4,360
2,933
2,543
5,680
5,6802,5432,9334,3603,214
   > Total Current Liabilities 
3,167
3,619
2,437
2,143
5,074
5,0742,1432,4373,6193,167
       Accounts payable 
1,411
1,430
629
503
3,540
3,5405036291,4301,411
       Other Current Liabilities 
5
6
4
0
65
650465
   > Long-term Liabilities 
47
741
496
400
606
60640049674147
> Total Stockholder Equity
18,613
9,629
3,864
22,120
10,172
10,17222,1203,8649,62918,613
   Common Stock00000
   Retained Earnings Total Equity00000
   Accumulated Other Comprehensive Income 00000
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 00000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue485
Cost of Revenue-120
Gross Profit365365
 
Operating Income (+$)
Gross Profit365
Operating Expense-13,344
Operating Income-12,859-12,979
 
Operating Expense (+$)
Research Development6,191
Selling General Administrative4,296
Selling And Marketing Expenses0
Operating Expense13,34410,487
 
Net Interest Income (+$)
Interest Income99
Interest Expense-130
Other Finance Cost-19
Net Interest Income-50
 
Pretax Income (+$)
Operating Income-12,859
Net Interest Income-50
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,101-12,859
EBIT - interestExpense = -130
-12,024
-11,894
Interest Expense130
Earnings Before Interest and Taxes (EBIT)0-11,971
Earnings Before Interest and Taxes (EBITDA)-11,222
 
After tax Income (+$)
Income Before Tax-12,101
Tax Provision--77
Net Income From Continuing Ops-12,024-12,024
Net Income-12,024
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net050
 

Technical Analysis of Epigenomics AG
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Epigenomics AG. The general trend of Epigenomics AG is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Epigenomics AG's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Epigenomics AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.625 < 1.785 < 1.81.

The bearish price targets are: 1.1 > 0.99 > 0.99.

Tweet this
Epigenomics AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Epigenomics AG. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Epigenomics AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Epigenomics AG.

Epigenomics AG Daily Moving Average Convergence/Divergence (MACD) ChartEpigenomics AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Epigenomics AG. The current adx is .

Epigenomics AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Epigenomics AG.

Epigenomics AG Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Epigenomics AG.

Epigenomics AG Daily Relative Strength Index (RSI) ChartEpigenomics AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Epigenomics AG.

Epigenomics AG Daily Stochastic Oscillator ChartEpigenomics AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Epigenomics AG.

Epigenomics AG Daily Commodity Channel Index (CCI) ChartEpigenomics AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Epigenomics AG.

Epigenomics AG Daily Chande Momentum Oscillator (CMO) ChartEpigenomics AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Epigenomics AG.

Epigenomics AG Daily Williams %R ChartEpigenomics AG Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Epigenomics AG.

Epigenomics AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Epigenomics AG.

Epigenomics AG Daily Average True Range (ATR) ChartEpigenomics AG Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Epigenomics AG.

Epigenomics AG Daily On-Balance Volume (OBV) ChartEpigenomics AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Epigenomics AG.

Epigenomics AG Daily Money Flow Index (MFI) ChartEpigenomics AG Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Epigenomics AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Epigenomics AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Epigenomics AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.320
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Epigenomics AG with someone you think should read this too:
  • Are you bullish or bearish on Epigenomics AG? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Epigenomics AG? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Epigenomics AG

I send you an email if I find something interesting about Epigenomics AG.


Comments

How you think about this?

Leave a comment

Stay informed about Epigenomics AG.

Receive notifications about Epigenomics AG in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.